Uruguay

Though current value sales are expected to rise, constant value sales are expected to fall, as continuing rising operating costs cut into profitability. In 2023, with concerns about COVID-19 abating, demand for analgesics reduces to more normal…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…

Dermatologicals is expected to register moderate constant value and volume growth in 2023. Dermatologicals continues to recover from the removal of pandemic restrictions. With patients again visiting doctors for the last two years, this is a…

For the second consecutive year, dietary supplements is expected to register a significant fall in volume sales. Two main factors are causing this negative performance. With concerns about COVID-19 abating, consumers are less concerned about boosting…